Investors worry that market correction will be lengthy
While a number of analysts report that their investors show no signs of panic after the late February meltdown in all biotech stocks, they remain nervous about the sector wondering if its tremendous performance over the past two years has finally come to an end. The two-day exodus from biotech certainly contributed to ugly returns in March.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter